D

Active Director Director DIN 10059693
DIN 10059693 First appointment Mar 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Dipika

Data last updated:

Dipika is a Director at Ramon Lifesciences Private Limited (since 2023). The company operates in Chemicals. Ramon Lifesciences Private Limited reported revenue of ₹19.4 Lakh (FY 2025).

DIN 10059693
Primary Designation Director
Industry Chemicals
First Appointment 01 Mar 2023
Oldest Company Age 5 yrs
Largest company Ramon Lifesciences Private Limited · ₹19.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ramon Lifesciences Private Limited U24290UP2021PTC154371
Director01 Mar 20232021₹19.4 Lakh (FY 2025)Active

Board colleagues of Dipika

NameDINCompanyDesignation
Abhishek Pandey09371735Ramon Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ramon Lifesciences Private Limited
Premium access

Shareholding and investment profile for Dipika

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipika

Dipika currently holds 1 directorship: Ramon Lifesciences Private Limited (Director, since 01 Mar 2023, revenue ₹19.4 Lakh (FY 2025)).

Dipika was first appointed on 01 Mar 2023 as Director at Ramon Lifesciences Private Limited.

The current boards of Dipika's companies include Abhishek Pandey (Ramon Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available